Although not statistically significant, there seemed to be a slight trend of efficacy reduction with time (from over 95 to 84–88%), and the long-lasting benefits seem to be slightly lower than traditional MUSs (TVT, TVT-O) [ 2 , 3 , 29 ]; however, more studies with a large sample size are needed to demonstrate this.
← all excerpts
Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up.
2
—
—
The sentences
A significant trend of de novo OAB symptoms was reported (22.2% [10/45]) at the 5-year follow-up.